Boston VA Research Institute, Inc.

Boston VA Research Institute, Inc., operating as Boston VA Research Institute, is a Boston-based nonprofit research organization that serves as a prime recipient of federal grants and federal research funding in biomedical and behavioral sciences, with particular emphasis on veterans' health outcomes and military-connected populations. The organization operates predominantly as a grant recipient (72% of 111 recent awards) under the Defense Health Agency, National Institutes of Health, and the Department of Veterans Affairs, alongside subcontract and sub-recipient engagement with academic medical centers and research foundations (28% of awards).

Boston VA Research Institute's capability portfolio centers on hypothesis-driven translational research, clinical trials, neuroscience and neuroimaging, genomics and precision oncology, mental health interventions, and aging-related disease mechanisms. Recent prime grant work includes a $997,393 three-year project grant awarded by the Defense Health Agency on 1 July 2026 investigating hemoglobin A1C stability and dementia risk in older adults with diabetes, concluding 30 June 2029; a $2.9 million four-year project grant from the Defense Health Agency (awarded 30 September 2023, completing 29 September 2027) studying long-term psychological and physical health outcomes in veterans post-deployment under the Veterans After-Discharge Longitudinal Registry (Project VALOR); and a cooperative agreement from the National Human Genome Research Institute (awarded 23 September 2024, completing 31 January 2030) implementing genomic medicine across diverse veteran communities. The organization also holds active grants from the National Institute of Mental Health (CFDA 93.242) investigating spectral components of abnormal gamma activity in schizophrenia ($128 thousand, running through 31 March 2027) and real-time fMRI neurofeedback for auditory hallucinations in schizophrenia patients. National Institute on Aging project grants address photobiomodulation for Alzheimer's disease progression and frailty prevention in older adults.

Customer concentration sits heavily with the Defense Health Agency (19 awards), the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 (14 awards, $650 thousand combined potential value), and the National Institute on Aging (9 awards). The top five customers by award count account for 50% of recent awards; the Defense Health Agency, VA VISN 1, and NIH/NIA dominate the footprint. The source reports 111 total awards (prime plus sub) with $1.8 million in combined potential value but $99.6 million in combined obligated dollars, indicating substantial obligated funding that dwarfs formal potential-value listings — a common reporting pattern for research grants where invoiced spend may exceed published ceilings.

Boston VA Research Institute operates as a sub-recipient across 31 recent awards, partnering with major research institutions including the University of Kansas Center for Research, Vanderbilt University Medical Center, Beth Israel Deaconess Medical Center, Harvard College, the Henry M. Jackson Foundation, Dana-Farber Cancer Institute, and the University of Texas Health Science Center at San Antonio. Representative subaward work includes contributing neuropsychological expertise and data analyses to clinical trials on post-traumatic stress disorder, insomnia and traumatic brain injury, multiple sclerosis treatment outcomes, and cancer risk prediction in veterans using electronic health record data and artificial intelligence methods. The organization also supplies biosamples and clinical data to Department of Defense Cancer Moonshot initiatives (APOLLO and PROMETHEUS programs) studying military-related toxic exposures and cancer risk.

Activity has grown materially in recent years — six awards in 2022, eight in 2023, sixteen in 2024, ten in 2025, and four through mid-2026 — with seven awards (data not shown on combined value but representing active clinical and translational grants) scheduled for ultimate completion within the next twenty-four months. Boston VA Research Institute's award portfolio reflects a nonprofit research institute tightly affiliated with VA Boston Healthcare System, leveraging the VA's clinical EHR infrastructure, veteran patient populations, and existing research collaborations with Boston-area academic medical institutions to compete for competitive federal biomedical research funding from NIH, DoD, and VA. The organization does not hold parent contract vehicles, IDIQs, or government-wide acquisition contracts; its footprint is entirely grant and research-support-services-driven.